NCT07022756

Brief Summary

The primary goal of this study is to determine whether providing patient honoraria and/or outreach services can improve the attendance rate of appointments at an inner city rheumatology clinic in Vancouver, British Columbia. The main question it aims to answer are:

  • Does providing a financial honorarium ($20 for each follow-up appointment with completed bloodwork) improve attendance rate at an inner city rheumatology clinic?
  • Does providing a personalized outreach service for rheumatic diseases improve attendance rate at an inner city rheumatology clinic? The researchers will compare providing patient honoraria to providing both honoraria and outreach services, and compare each of these to the regular appointment schedule without honoraria or outreach. Participants will:
  • Undergo randomization to receive honoraria or honoraria and outreach services together
  • Complete surveys about their health and understanding of their rheumatic disease at baseline, 3-month, and 6-month intervals
  • Visit the clinic every month for check-ups and monitoring bloodwork if they are started on immunosuppressants for their condition

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 7, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 15, 2025

Completed
17 days until next milestone

Study Start

First participant enrolled

July 2, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Completed
Last Updated

July 4, 2025

Status Verified

July 1, 2025

Enrollment Period

9 months

First QC Date

June 7, 2025

Last Update Submit

July 1, 2025

Conditions

Keywords

RheumatologyInflammatory ArthritisInner City Health

Outcome Measures

Primary Outcomes (1)

  • Attendance at in-person follow-up appointments

    Adherence to in-person follow-up measured by the ratio of appointments attended to appointments scheduled.

    Cumulative over 6 months

Secondary Outcomes (4)

  • Clinical Disease Activity Index (CDAI)

    3-month and 6-month intervals.

  • Patient Qualitative Feedback

    3-month and 6-month intervals.

  • Patient Reported Understanding of Disease and Medications

    3-month and 6-month intervals.

  • Patient reported pain related to arthritis

    3-month and 6-month intervals

Other Outcomes (5)

  • Tender Joint Count

    At the 6-month interval.

  • Swollen joint count

    At the 6-month interval.

  • Number of Emergency Department Visits During the Study Period

    Cumulative over 6 months

  • +2 more other outcomes

Study Arms (3)

Honoraria Only

ACTIVE COMPARATOR

Participants in this arm of the study will only receive honoraria and not outreach

Behavioral: Honoraria

Honoraria and Outreach

EXPERIMENTAL

Participants in this arm of the study will receive both honoraria and outreach services

Behavioral: HonorariaBehavioral: Outreach

Historical Control

NO INTERVENTION

The attendance rate to follow-up appointments among all patients with inflammatory arthritis due to a rheumatic disease at the Pender Rheumatology Clinic from Jan 2023 to Jun 2025.

Interventions

HonorariaBEHAVIORAL

A $20 honorarium for each appointment attended with completed bloodwork if requested.

Honoraria OnlyHonoraria and Outreach
OutreachBEHAVIORAL

A personalized outreach service specific for rheumatic disease.

Honoraria and Outreach

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Have a diagnosis of inflammatory arthritis secondary to an autoimmune rheumatic disease
  • Be attached to one of the Vancouver Coastal Health Community Health Centres for primary care
  • Be willing to attend in-person appointments at Pender Community Health Centre
  • Be at least 18 years of age and capable of consenting to participation
  • Be able to receive medical care in English.

You may not qualify if:

  • Have cognitive impairment or an untreated psychiatric condition that would severely impair ability to engage with outreach or treatment
  • Have no reasonably reliable method of contact (phone, email, social media, etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pender Community Health Centre

Vancouver, British Columbia, Canada

Location

MeSH Terms

Conditions

Rheumatic DiseasesArthritisArthritis, RheumatoidArthritis, PsoriaticConnective Tissue Diseases

Interventions

Community-Institutional Relations

Condition Hierarchy (Ancestors)

Musculoskeletal DiseasesSkin and Connective Tissue DiseasesJoint DiseasesAutoimmune DiseasesImmune System DiseasesSpondylarthropathiesSpondylarthritisSpondylitisSpinal DiseasesBone DiseasesPsoriasisSkin Diseases, PapulosquamousSkin Diseases

Intervention Hierarchy (Ancestors)

Public RelationsOrganization and AdministrationHealth Services Administration

Study Officials

  • Brent R Ohata, MD

    University of British Columbia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Chu Ming (Alec) Yu, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lead Investigator - Personalized Outreach for Equitable Treatment in Rheumatology

Study Record Dates

First Submitted

June 7, 2025

First Posted

June 15, 2025

Study Start

July 2, 2025

Primary Completion

April 1, 2026

Study Completion

June 1, 2026

Last Updated

July 4, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

We are working with a uniquely vulnerable population who are marginalized by extreme poverty, and feel that the risks of identification by sharing individual patient data outweigh the academic benefits in this study.

Locations